Cargando…

Prevalence and Factors Associated with Cumulative Anticholinergic Burden Among Older Long-Stay Nursing Home Residents with Overactive Bladder

BACKGROUND: Overactive bladder (OAB), the primary cause of urinary incontinence in nursing homes, is commonly treated with anticholinergic medications; however, the elderly population is vulnerable to the adverse effects associated with anticholinergic burden. Given the relatively high prevalence of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chatterjee, Satabdi, Walker, David, Kimura, Tomomi, Aparasu, Rajender R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007511/ https://www.ncbi.nlm.nih.gov/pubmed/33682017 http://dx.doi.org/10.1007/s40266-021-00833-x

Ejemplares similares

The Costs and Healthcare Resource Utilization Associated with Anticholinergic Burden in Long-Stay Nursing Home Residents with Overactive Bladder in the US
por: Chatterjee, Satabdi, et al.
Publicado: (2021)

Fall/Fracture-Related Healthcare Costs and Their Association with Cumulative Anticholinergic Burden in People with Overactive Bladder
por: Lozano-Ortega, Greta, et al.
Publicado: (2020)

Antipsychotic Use and Risk of Nursing Home Admission Among Dual-Eligible Medicare Beneficiaries: A Propensity-Matched Study
por: Aparasu, Rajender R., et al.
Publicado: (2015)

Association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder: US-based retrospective cohort study
por: Szabo, Shelagh M, et al.
Publicado: (2019)

Antimuscarinic Discontinuation in Patients with Overactive Bladder in Nursing Homes: A Retrospective Study of Medicare Beneficiaries
por: Aparasu, Rajender R., et al.
Publicado: (2020)

Anticholinergic Burden and Associated Healthcare Resource Utilization in Older Adults with Overactive Bladder
por: Jaggi, Ashley, et al.
Publicado: (2021)

Effect of Desmopressin with Anticholinergics in Female Patients with Overactive Bladder
por: Han, Young Kook, et al.
Publicado: (2011)

Refractory overactive bladder: Beyond oral anticholinergic therapy
por: Glinski, Ronald W., et al.
Publicado: (2007)

Cognitive Effects of Anticholinergic Load in Women with Overactive Bladder
por: Araklitis, George, et al.
Publicado: (2020)

The Impact of Gene Polymorphisms on the Success of Anticholinergic Treatment in Children with Overactive Bladder
por: Gurocak, Serhat, et al.
Publicado: (2015)

Mirabegron and Anticholinergics in the Treatment of Overactive Bladder Syndrome: A Meta-analysis
por: Sartori, Luisa Gracio Ferreira, et al.
Publicado: (2023)

Measuring cumulative anticholinergic medicines burden in older Australian women
por: Parkinson, Lynne, et al.
Publicado: (2017)

Polypharmacy and cumulative anticholinergic burden in older adults hospitalized with fall
por: Wong, Ho Lun, et al.
Publicado: (2023)

Application of machine learning in predicting hospital readmissions: a scoping review of the literature
por: Huang, Yinan, et al.
Publicado: (2021)

Health Resource Utilization and Cost for Patients with Incontinent Overactive Bladder Treated with Anticholinergics
por: Yehoshua, Alon, et al.
Publicado: (2016)

Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions
por: Rutman, Matthew P., et al.
Publicado: (2021)

Dose response relationship of cumulative anticholinergic exposure with incident dementia: validation study of Korean anticholinergic burden scale
por: Suh, Yewon, et al.
Publicado: (2020)

Clinical Efficacy in the Treatment of Overactive Bladder Refractory to Anticholinergics by Posterior Tibial Nerve Stimulation
por: Arrabal-Polo, Miguel Angel, et al.
Publicado: (2012)

Efficacy and Tolerability of Anticholinergics in Korean Children with Overactive Bladder: A Multicenter Retrospective Study
por: Park, Se Jin, et al.
Publicado: (2014)

Anticholinergic Burden, Sleep Quality and Health Outcomes in Malaysian Aged Care Home Residents
por: Kumar, Suresh, et al.
Publicado: (2019)

Erratum: Efficacy and Tolerability of Anticholinergics in Korean Children with Overactive Bladder: A Multicenter Retrospective Study
por: Park, Se Jin, et al.
Publicado: (2015)

Patient and Clinician Challenges with Anticholinergic Step Therapy in the Treatment of Overactive Bladder: A Narrative Review
por: Dmochowski, Roger R., et al.
Publicado: (2023)

A 12-Year Retrospective Study of the Prevalence of Anticholinergic Polypharmacy and Associated Outcomes Among Medicare Patients with Overactive Bladder in the USA
por: Campbell, Noll L., et al.
Publicado: (2021)

The Efficacy and Safety of Propiverine Hydrochloride in Patients with Overactive Bladder Symptoms Who Poorly Responded to Previous Anticholinergic Agents
por: Masumori, Naoya, et al.
Publicado: (2011)

Temporary cognitive impairment related to administration of newly developed anticholinergic medicines for overactive bladder: two case reports
por: Shiota, Takako, et al.
Publicado: (2014)

Rationale for the Use of Anticholinergic Agents in Overactive Bladder With Regard to Central Nervous System and Cardiovascular System Side Effects
por: Çetinel, Bülent, et al.
Publicado: (2013)

Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real‐world claims data analysis
por: Sussman, D., et al.
Publicado: (2017)

The Impact of Anticholinergic Use for Overactive Bladder on Cognitive Changes in Adults with Normal Cognition, Mild Cognitive Impairment, or Dementia
por: Welk, Blayne, et al.
Publicado: (2022)

Factors influencing prescribing the first add-on disease-modifying antirheumatic drugs in patients initiating methotrexate for rheumatoid arthritis
por: Huang, Yinan, et al.
Publicado: (2023)

OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder
por: Sievert, K-D, et al.
Publicado: (2014)

Anticholinergic burden and comorbidities in patients attending treatment with trospium chloride for overactive bladder in a real-life setting: results of a prospective non-interventional study
por: Ivchenko, A., et al.
Publicado: (2018)

Impact of programs to reduce antipsychotic and anticholinergic use in nursing homes
por: Carnahan, Ryan M., et al.
Publicado: (2017)

Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study
por: Just, Katja S., et al.
Publicado: (2023)

ANNUALIZED AND CUMULATIVE MEASURES OF ANTICHOLINERGIC EXPOSURE FOR RESEARCH AND CLINICAL APPLICATIONS
por: Khalil, Hussein, et al.
Publicado: (2022)

Monotherapy with mirabegron had a better tolerance than the anticholinergic agents on overactive bladder: A systematic review and meta-analysis
por: Yi, Wei, et al.
Publicado: (2021)

Long-term efficacy and safety of vibegron versus mirabegron and anticholinergics for overactive bladder: a systematic review and network meta-analysis
por: Kennelly, Michael, et al.
Publicado: (2022)

Mirabegron and antimuscarinic use in frail overactive bladder patients in the United States Medicare population
por: Johnson, Theodore M., et al.
Publicado: (2022)

Depression in elderly women resident in a long-stay nursing home
por: Lampert, Melissa Agostini, et al.
Publicado: (2015)

Assessment of Anticholinergic Use After Fading of BTX-A Effects in Refractory Idiopathic Overactive Bladder: A Prospective Blinded Randomized Trial
por: Elbaset, M.A., et al.
Publicado: (2019)

Anticholinergic Burden of Geriatric Ward Inpatients
por: Wilczyński, Krzysztof, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5th4gam5d5cbhj6jujrise7163